Literature DB >> 24248552

Adenovirus type 3 induces platelet activation in vitro.

Ying-Yu Jin1, Xiu-Nan Yu, Zhang-Yi Qu, Ai-Ai Zhang, Yu-Ling Xing, Li-Xin Jiang, Lei Shang, Ying-Chen Wang.   

Abstract

In the present study, we aimed to investigate platelet activation induced by adenovirus type 3 (HAdV3) in vitro. Platelet-rich plasma (PRP) or whole blood was incubated with or without HAdV at various concentrations. Platelet aggregation, platelet counting, fibrinogen and expression of platelet membrane antigens (CD41a and CD62P) were determined following incubation with HAdV for different periods of time. The results demonstrated that HAdV at the concentrations of 109-1011 vp/ml enhanced adenosine diphosphate (ADP) or ristocetin-induced platelet aggregation, however did not alter the platelet count. Infection with HAdVs also reduced fibrinogen level. P-selectin and CD41a appeared rapidly on the surface after platelets were incubated with HAdVs in vitro for 30 min. In conclusion, HAdVs may induce activation of platelets and lead to a pre-thrombotic state of peripheral blood. This finding may aid in the development of measures to prevent severe HAdV infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24248552     DOI: 10.3892/mmr.2013.1805

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling.

Authors:  Meenakshi Banerjee; Yunjie Huang; Smita Joshi; Gabriel J Popa; Michael D Mendenhall; Qing Jun Wang; Beth A Garvy; Thein Myint; Sidney W Whiteheart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-21       Impact factor: 8.311

Review 2.  Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis.

Authors:  Linyi Chen; Xianming Cai; Tianshuo Zhao; Bingfeng Han; Mingzhu Xie; Jiahao Cui; Jiayu Zhang; Chao Wang; Bei Liu; Qingbin Lu; Fuqiang Cui
Journal:  Vaccines (Basel)       Date:  2022-04-12

3.  Cardiovascular and haematological events post COVID-19 vaccination: A systematic review.

Authors:  Dana Al-Ali; Abdallah Elshafeey; Malik Mushannen; Hussam Kawas; Ameena Shafiq; Narjis Mhaimeed; Omar Mhaimeed; Nada Mhaimeed; Rached Zeghlache; Mohammad Salameh; Pradipta Paul; Moayad Homssi; Ibrahim Mohammed; Adeeb Narangoli; Lina Yagan; Bushra Khanjar; Sa'ad Laws; Mohamed B Elshazly; Dalia Zakaria
Journal:  J Cell Mol Med       Date:  2021-12-29       Impact factor: 5.310

Review 4.  Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.

Authors:  Piotr Rzymski; Bartłomiej Perek; Robert Flisiak
Journal:  Vaccines (Basel)       Date:  2021-05-27

5.  To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia.

Authors:  Maha Othman; Alexander T Baker; Elena Gupalo; Abdelrahman Elsebaie; Carly M Bliss; Matthew T Rondina; David Lillicrap; Alan L Parker
Journal:  J Thromb Haemost       Date:  2021-08-23       Impact factor: 16.036

Review 6.  To aspirate or not to aspirate? Considerations for the COVID-19 vaccines.

Authors:  Piotr Rzymski; Andrzej Fal
Journal:  Pharmacol Rep       Date:  2022-03-23       Impact factor: 3.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.